HEALTHCARE

Market Overview: Biobanking is defined as a process by which samples of bodily fluid or tissue are collected for research. The collected sample is meant to improve the doctor's understanding of health and disease. A new report on the global Biobanking Market Overview , published by Market Research Future (MRFR), concludes that this market can view gains at 7.6% CAGR   between 2018 and 2023 . The data received from samples can often be used for several purposes. Rising demand for biosamples, tumor cells for clinical trials and others can provide substantial traction to the market. The increasing rate of investment from both the private and public sector can trigger impressive growth. However, the biobanking market is also getting muddled by a lot of ethical questions owing to which the expected rise could drop a little during the forecast period. Key Players: ·          Becton Dickinson & Company ·    ...

Market Overview: Biobanking is defined as a process by which samples of bodily fluid or tissue are collected for research. The collected sample is meant to improve the doctor's understanding of health and disease. A new report on the global Biobanking Market , published by Market Research Future (MRFR), concludes that this market can view gains at 7.6% CAGR   between 2018 and 2023 . The most important market drivers for the global biobanking market growth are increasing applications in life sciences and increasing demand for research activities in genomics for studying various diseases. The increasing research & development (R&D) is strengthening the global biobanking market. Other market drivers that are responsible for the global biobanking market growth include increasing government as well as private funding to support the regenerative medicine research, growing penetration by market players, and increasing technical advanced devices. Today the medical sector i...